CANADA LIFE ASSURANCE Co increased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 6.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 155,886 shares of the company's stock after buying an additional 9,141 shares during the period. CANADA LIFE ASSURANCE Co owned about 0.13% of Clorox worth $25,317,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds also recently bought and sold shares of the stock. Brooklyn Investment Group boosted its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in shares of Clorox in the 4th quarter valued at about $26,000. Millstone Evans Group LLC bought a new stake in shares of Clorox in the 4th quarter valued at about $31,000. Asset Planning Inc purchased a new position in shares of Clorox in the 4th quarter worth approximately $32,000. Finally, GKV Capital Management Co. Inc. purchased a new stake in Clorox during the fourth quarter valued at approximately $32,000. Hedge funds and other institutional investors own 78.53% of the company's stock.
Analysts Set New Price Targets
A number of equities analysts have recently issued reports on the company. Citigroup reduced their price target on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a research report on Monday, April 14th. Evercore ISI upped their target price on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. JPMorgan Chase & Co. lowered their price target on Clorox from $173.00 to $151.00 and set a "neutral" rating for the company in a report on Friday, April 11th. DA Davidson dropped their price target on Clorox from $171.00 to $169.00 and set a "neutral" rating on the stock in a research note on Wednesday, February 5th. Finally, Barclays decreased their price objective on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating for the company in a research report on Friday, April 11th. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $153.83.
View Our Latest Stock Analysis on Clorox
Clorox Stock Performance
NYSE:CLX traded down $1.61 during mid-day trading on Thursday, hitting $137.50. The company's stock had a trading volume of 1,221,087 shares, compared to its average volume of 1,302,437. The business's fifty day moving average is $146.01 and its two-hundred day moving average is $155.99. The stock has a market cap of $16.94 billion, a price-to-earnings ratio of 37.57, a PEG ratio of 2.62 and a beta of 0.61. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.
Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter last year, the business earned $2.16 EPS. Analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.55%. The ex-dividend date is Wednesday, April 23rd. Clorox's payout ratio is 133.33%.
Clorox Company Profile
(
Free Report)
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More

Before you consider Clorox, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.
While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.